DTaP-Hib vaccine

From WikiProjectMed
Jump to navigation Jump to search
DTaP-Hib vaccine
Combination of
DTaP vaccineVaccine
Hib vaccineVaccine
Names
Trade namesTriHIBit, ActHIB with Tripedia
Clinical data
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
use
Intramuscular injection
Identifiers
CAS Number
  • 1670254-07-5
ATC code

DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib.[1] It protects against five infectious diseases; diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.[1]

A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB.[2][3][4] TriHIBit and Tripedia were discontinued in 2011.[5]

References

  1. 1.0 1.1 "Trihibit (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid) Disease Interactions". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  2. "Notice to Readers FDA Approval of a Haemophilus b Conjugate Vaccine Combined by Reconstitution with an Acellular Pertussis Vaccine". Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 15 November 1996. pp. 993–995. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  3. "Tripedia package insert" (PDF). US Food and Drug Administration. Archived from the original (PDF) on 12 January 2017. Retrieved 15 July 2018.
  4. "ActHIB package insert" (PDF). US Food and Drug Administration. Archived (PDF) from the original on 13 February 2019. Retrieved 15 July 2018.
  5. "Selected Discontinued U.S. Vaccines" (PDF). Centers for Disease Control and Prevention. Archived (PDF) from the original on 23 November 2017. Retrieved 15 July 2018.